|
Forward Ventures, founded in 1993, has a team of five investment
professionals with extensive experience in venture capital and operations.
Forward has invested in over 50 companies since it was founded in
1993 and currently has approximately $500 million in capital under management.
The most recent fund, Forward V, continues Forward Ventures’ program of life
sciences and health care venture investing in companies of all stages. The firm
is headquartered in a 40,000 square-foot research building that also serves as
an incubator for its portfolio companies.
|
 |
|
|
| 3/21/2007 | | EISAI To Aquire Morphotek | | Morphotek Press Release | | more | | 3/5/2007 | | Lilly announces acquisition of Hypnion | | Hypnion Press Release | | more | | 1/11/2007 | | Dr. Ivor Royston talked about his career and his transition from research scientist to entrepreneur and then venture capitalist on I’m There for You Baby: The Entrepreneur’s Guide to the Galaxy. | | The Entrepreneur’s Guide to the Galaxy | | more |
|
|
|
| 7/25/2007 | | Merck & Co., Inc. to Acquire NovaCardia, Inc., to Boost Clinical Pipline of Cardiovascular Drug Candidates | | NovaCardia Press Release | | more | | 7/12/2007 | | TargeGen, Inc. Closes $40M Series “D” Financing Round | | Targegen Press Release | | more | | 5/29/2007 | | Avalon Pharmaceuticals Closes $20 Million in Private Placement of Common Stock and Warrants to Institutional Investors | | Avalon Press Release | | more | | 5/9/2007 | | TargeGen Receives 2007 James D. Watson Helix Award | | TargeGen Press Release | | more | | 5/9/2007 | | Avalon Pharmaceuticals Reports First Quarter 2007 Results | | Avalon Press Release | | more |
|
|
|
|
 |